- Home
- TNXP vs ABAT Comparison
TNXP vs ABAT Comparison
Compare TNXP & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- ABAT
- Stock Information
- Founded
- TNXP 2007
- ABAT 2011
- Country
- TNXP United States
- ABAT United States
- Employees
- TNXP N/A
- ABAT N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- ABAT Metal Mining
- Sector
- TNXP Health Care
- ABAT Basic Materials
- Exchange
- TNXP Nasdaq
- ABAT Nasdaq
- Market Cap
- TNXP 71.6M
- ABAT 71.7M
- IPO Year
- TNXP N/A
- ABAT N/A
- Fundamental
- Price
- TNXP $0.38
- ABAT $1.38
- Analyst Decision
- TNXP Strong Buy
- ABAT
- Analyst Count
- TNXP 2
- ABAT 0
- Target Price
- TNXP $53.50
- ABAT N/A
- AVG Volume (30 Days)
- TNXP 102.7M
- ABAT 5.2M
- Earning Date
- TNXP 11-12-2024
- ABAT 02-16-2025
- Dividend Yield
- TNXP N/A
- ABAT N/A
- EPS Growth
- TNXP N/A
- ABAT N/A
- EPS
- TNXP N/A
- ABAT N/A
- Revenue
- TNXP $11,291,000.00
- ABAT $545,460.00
- Revenue This Year
- TNXP $64.71
- ABAT $31,748.62
- Revenue Next Year
- TNXP $24.49
- ABAT N/A
- P/E Ratio
- TNXP N/A
- ABAT N/A
- Revenue Growth
- TNXP 183.05
- ABAT N/A
- 52 Week Low
- TNXP $0.12
- ABAT $0.73
- 52 Week High
- TNXP $12.48
- ABAT $4.11
- Technical
- Relative Strength Index (RSI)
- TNXP 55.72
- ABAT 41.56
- Support Level
- TNXP $0.37
- ABAT $1.23
- Resistance Level
- TNXP $0.58
- ABAT $1.53
- Average True Range (ATR)
- TNXP 0.07
- ABAT 0.21
- MACD
- TNXP 0.01
- ABAT -0.11
- Stochastic Oscillator
- TNXP 43.06
- ABAT 14.29
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.